Firms
Theme

SNPS

Synopsys Inc · NASDAQ

News

17 latest

Zacks Investment Research

Synopsys (SNPS) Rises As Market Takes a Dip: Key Facts

Synopsys (SNPS) closed at $430.14, up 1.81%, outperforming the S&P 500. The chip design software maker has a Zacks Rank #1 (Strong Buy) rating with projected EPS growth of 42.07% and revenue growth of 13.38% for the upcoming quarter. The company trades at a Forward P/E of 27.91, above its industry average, with a PEG ratio of 1.25.

Zacks Investment Research

Can Synopsys' AI-Focused Design IP Strategy Drive Growth?

Synopsys' Design IP revenues grew 11% year-over-year in fiscal Q3 2026, reaching 19.1% of total revenues, with the IP business on track to double year-over-year and exceeding 100 cumulative design wins. The company maintains strong automotive design-win rates above 90% for three consecutive quarters as ADAS transitions to advanced chip technologies. However, SNPS stock trades at a premium valuation of 8.44X P/S multiple, significantly above the industry average of 6.37X.

Zacks Investment Research

Synopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should Know

Synopsys (SNPS), a chip testing and development software maker, has gained 26.8% over the past month, significantly outperforming the S&P 500's 2.1% gain. The company holds a Zacks Rank #1 (Strong Buy) rating based on strong earnings estimate revisions and consistent beat history.

Zacks Investment Research

Synopsys Rises 34.5% in a Month: Should You Buy the Stock Now?

Synopsys (SNPS) stock has surged 34.5% in the past month, driven by AI infrastructure demand and the Ansys acquisition which contributed 28.7% of Q2 fiscal 2026 revenue. With 82% recurring revenue, a $10.9 billion backlog, and a strategic NVIDIA partnership, the company is expanding its EDA capabilities with AI-powered solutions. However, the stock trades at a premium P/S multiple of 8.7x versus the industry average of 6.47x. Analysts recommend accumulating SNPS as a Zacks Rank #1 Strong Buy despite the elevated valuation.

Zacks Investment Research

Zacks Investment Ideas feature highlights: Synopsys and Amazon

Synopsys (SNPS) is positioned as a potential AI infrastructure winner following major partnerships with Amazon and OpenAI, stronger-than-expected fiscal 2027 guidance, and accelerating analyst revisions. The stock is approaching a major technical breakout above $510-$520 resistance after years of consolidation, with management targeting 15% annual revenue growth and mid-20% EPS growth through fiscal 2030.

Zacks Investment Research

Synopsys (SNPS): The Next Big AI Stock Breakout?

Synopsys (SNPS), a semiconductor design software provider, is positioned as a potential AI infrastructure beneficiary following major partnerships with Amazon and OpenAI, stronger-than-expected fiscal 2027 guidance, and accelerating analyst revisions. The stock is approaching a major technical breakout above $510-$520 resistance on its quarterly chart, with management targeting mid-20% annual earnings growth through fiscal 2030.

Zacks Investment Research

PRGS vs. SNPS: Which Stock Should Value Investors Buy Now?

Both Progress Software (PRGS) and Synopsys (SNPS) hold a Zacks Rank #1 (Strong Buy) with positive earnings outlooks. However, based on valuation metrics, PRGS emerges as the superior value option with a forward P/E of 6.04 compared to SNPS's 32.29, a PEG ratio of 1.21 vs 1.44, and a Value grade of A versus F.

Zacks Investment Research

How to Find Strong Buy Computer and Technology Stocks Using the Zacks Rank

The article explains the Zacks Rank stock-rating system, which uses earnings estimate revisions to identify strong investment opportunities. The system has beaten the S&P 500 in 26 of the last 32 years with an average annual return of +23.86%. Synopsys (SNPS) is highlighted as a recent Strong Buy addition with seven analysts revising earnings estimates upward, projected earnings growth of 17.2%, and a 24% gain over four weeks.

The Motley Fool

Prediction: This Under-the-Radar AI Stock Will Soar Over the Next Decade

Synopsys has attracted analyst enthusiasm following its investor day presentation and a $1 billion multi-year agreement with Amazon for custom silicon innovation. The company is expanding beyond traditional EDA solutions into physical AI applications through its Ansys acquisition, positioning itself to offer silicon-to-systems solutions. Management's aggressive long-term growth targets suggest attractive valuations by 2030, though success depends on market adoption of in-house chip design trends.

GlobeNewswire Inc.

2026 BayAreaCISO ORBIE Awards Recognize Bay Area’s Top Security Executives

The 2026 BayAreaCISO ORBIE Awards recognized six leading CISOs for exceptional security leadership and business impact. Winners included executives from Monolithic Power Systems, Synopsys Inc., TriNet, Dayforce, SLAC National Accelerator Laboratory, and ABC Fitness. The awards ceremony, held at the Santa Clara Marriott with over 180 attendees, honored CISOs across six categories based on leadership effectiveness, business protection, and industry engagement.

The Motley Fool

Why Synopsys Stock Soared on Thursday

Synopsys stock jumped 12.5% after announcing at its Investor Day that it expects revenue to grow up to 15% to $11.2 billion in 2027, exceeding analyst expectations of $11 billion. The company projects a 20.7% operating profit margin and non-GAAP margins averaging 44%. The article discusses the valuation debate between GAAP earnings (P/E of 58x) versus non-GAAP earnings (P/E of 25.4x), with free cash flow metrics supporting the non-GAAP valuation at approximately 25x FCF.

Zacks Investment Research

Amazon Inks $1B SNPS Deal to Power AWS Custom Chips: Should You Hold?

Amazon signed a $1B+ multi-year IP agreement with Synopsys to accelerate custom chip design for AWS. AWS revenues grew 37% to $42.2B in Q2 with a $496B backlog, while Amazon's chips business surpassed $25B annual revenue run rate.

Zacks Investment Research

Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It

Synopsys (SNPS), a chip testing and development software maker, has outperformed the S&P 500 over the past month with a +4.6% return. The company shows strong earnings growth of +41.4% year-over-year for the current quarter and revenue growth of +37.8% for the current fiscal year. With a Zacks Rank #2 (Buy) rating and a consistent track record of beating consensus estimates, the stock may outperform the broader market in the near term, though it trades at a premium valuation relative to peers.

Mentions SNPS

Zacks Investment Research

Intuit Expands NFL Partnership to Boost Intuit Intelligence Reach

Intuit has extended its NFL partnership through 2030, expanding to four international markets to showcase Intuit Intelligence—its integrated AI platform combining data, AI, and human expertise across TurboTax, Credit Karma, QuickBooks, and Mailchimp. The campaign will feature Peyton Manning and the Kittles throughout the season, leveraging the platform's reach of 82 million consumers, 10 million businesses, and 650,000 accountants to drive adoption of its AI-powered products.

Zacks Investment Research

Stock Market News for Oct 1, 2026

U.S. stock markets finished mixed on Wednesday as investors remained concerned about rising government bond yields, despite softer-than-expected PCE inflation and stronger-than-expected Q2 GDP growth of 2.2%. The Dow fell 0.9%, the S&P 500 declined 0.3%, while the Nasdaq Composite rose 0.2%.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $SNPS · 0 threads

Sign in to post on $SNPS

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev